Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 19:16:1554170.
doi: 10.3389/fphar.2025.1554170. eCollection 2025.

Gastrodin: a potential natural product for the prevention and treatment of cerebral ischemia-reperfusion injury

Wenxiu Qin #  1   2   3 , Jianqiang Du #  1   2   3 , Feng Wang  1   2 , Junfeng Xu  1   2
Affiliations
Review

Gastrodin: a potential natural product for the prevention and treatment of cerebral ischemia-reperfusion injury

Wenxiu Qin et al. Front Pharmacol. .

Abstract

Ethnopharmacological relevance: Gastrodin is the main bioactive metabolite of Gastrodia elata Blume of traditional Chinese medicine, which has pharmacological effects such as anti-inflammatory, antioxidant, neuroprotective, vasoprotective, hypoglycemic, lipotropic, analgesic, anticancer, antiviral and so on, and it has been widely used in the treatment of a wide range of diseases, especially neurological disorders.

Aim of the review: Cerebral ischemia-reperfusion injury (CIRI) is defined as transient or permanent ischemia of brain tissue that is further exacerbated by restoration of blood supply. Due to the complexity of the pathological processes of CIRI, current treatments have not shown the expected effects. More and more researchers are beginning to turn their focus on combating CIRI to natural metabolites derived from botanical drugs. This review provides an overview of the progress of research on the chemical composition, pharmacokinetics, safety, and pharmacological effects of Gastrodin in the treatment of CIRI. It aims to emphasize the important pharmacological effects and mechanisms of Gastrodin in the prevention and treatment of CIRI, and to provide reference for further drug research and development, as well as the future application of Gastrodin in CIRI.

Materials and methods: A systematic literature search was conducted using keywords such as "Gastrodin," "traditional Chinese medicine," "chemical components," "metabolites," "cerebral ischemia-reperfusion injury," "CIRI," and "pharmacological effects" to identify relevant literature published from the establishment of the database to January 2025. Databases including PubMed, Web of Science, Google Scholar, and CNKI were utilized. Raw data were included in clinical trials and animal experiments. Other studies, such as reviews and systematic evaluations, were excluded.

Results: GAS can prevent and treat cerebral ischemia/reperfusion-induced neurological injury by regulating a variety of molecular signals, exerting pharmacological effects such as anti-oxidative stress, inhibition of inflammatory response, inhibition of cell death, modulation of neurotransmitters, alleviation of neurotoxicity, promotion of neural repair, protection of the blood-brain barrier, and alleviation of cerebral edema, making it a potential natural metabolite for the effective treatment of CIRI.

Conclusion: Gastrodin has significant value in the treatment of CIRI and there is extensive evidence to support its use in CIRI. Further research and clinical exploration of Gastrodin is necessary to fully utilize its therapeutic potential.

Keywords: Gastrodin; cerebral ischemia-reperfusion injury; neuroprotection; pharmacological effects; traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Neuroprotective mechanisms of CIRI treated with GAS.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Abdullahi W., Tripathi D., Ronaldson P. T. (2018). Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am. J. Physiol. Cell Physiol. 315 (3), C343–C356. 10.1152/ajpcell.00095.2018 - DOI - PMC - PubMed
    1. Alves D. S. M., Smidt M. P. (2011). En1 and Wnt signaling in midbrain dopaminergic neuronal development. Neural Dev. 6, 23. 10.1186/1749-8104-6-23 - DOI - PMC - PubMed
    1. An P., Xie J., Qiu S., Liu Y., Wang J., Xiu X., et al. (2019). Hispidulin exhibits neuroprotective activities against cerebral ischemia reperfusion injury through suppressing NLRP3-mediated pyroptosis. Life Sci. 232, 116599. 10.1016/j.lfs.2019.116599 - DOI - PubMed
    1. Atanasov A. G., Zotchev S. B., Dirsch V. M., Supuran C. T. (2021). Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20 (3), 200–216. 10.1038/s41573-020-00114-z - DOI - PMC - PubMed
    1. Bao M. H., Szeto V., Yang B. B., Zhu S. Z., Sun H. S., Feng Z. P. (2018). Long non-coding RNAs in ischemic stroke. Cell Death Dis. 9 (3), 281. 10.1038/s41419-018-0282-x - DOI - PMC - PubMed

LinkOut - more resources